Business Description
ARCA biopharma Inc
NAICS : 325413
SIC : 2835
ISIN : US00211Y4070
Description
ARCA biopharma Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to the development and commercialization of targeted therapies for cardiovascular diseases. The company's product candidates are rNAPc2 as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro for the treatment of atrial fibrillation, or AF, in patients with chronic heart failure, or HF. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 176 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 37.6 | |||||
3-Year EPS without NRI Growth Rate | 43.7 | |||||
3-Year FCF Growth Rate | 40.4 | |||||
3-Year Book Growth Rate | -19.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 17.71 | |||||
9-Day RSI | 29.01 | |||||
14-Day RSI | 36.45 | |||||
6-1 Month Momentum % | 117.68 | |||||
12-1 Month Momentum % | 75.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 23.19 | |||||
Quick Ratio | 23.19 | |||||
Cash Ratio | 22.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.9 | |||||
Shareholder Yield % | 0.15 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -15.8 | |||||
ROA % | -15.24 | |||||
ROIC % | -2016.68 | |||||
ROC (Joel Greenblatt) % | -3298.35 | |||||
ROCE % | -20.92 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.3 | |||||
Price-to-Tangible-Book | 1.3 | |||||
EV-to-EBIT | -1.14 | |||||
EV-to-EBITDA | -1.15 | |||||
EV-to-FCF | -1.83 | |||||
Price-to-Net-Current-Asset-Value | 1.3 | |||||
Price-to-Net-Cash | 1.32 | |||||
Earnings Yield (Greenblatt) % | -87.72 | |||||
FCF Yield % | -10.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ABIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ARCA biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.42 | ||
Beta | -0.49 | ||
Volatility % | 100.34 | ||
14-Day RSI | 36.45 | ||
14-Day ATR ($) | 0.234352 | ||
20-Day SMA ($) | 3.41825 | ||
12-1 Month Momentum % | 75.86 | ||
52-Week Range ($) | 1.56 - 4.49 | ||
Shares Outstanding (Mil) | 14.51 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ARCA biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ARCA biopharma Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
ARCA biopharma Inc Frequently Asked Questions
What is ARCA biopharma Inc(ABIO)'s stock price today?
The current price of ABIO is $3.14. The 52 week high of ABIO is $4.49 and 52 week low is $1.56.
When is next earnings date of ARCA biopharma Inc(ABIO)?
The next earnings date of ARCA biopharma Inc(ABIO) is 2024-07-26 Est..
Does ARCA biopharma Inc(ABIO) pay dividends? If so, how much?
ARCA biopharma Inc(ABIO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |